Abstract
Patients with DEL phenotype, a D variant with a low number of D antigens per red blood cell, are routinely typed as RhD-negative in serology testing and are detectable only by adsorption and elution techniques or molecular methods. DEL is of clinical importance worldwide, as indicated by its genotype-phenotype discrepancies among different populations and its potential to cause anti-D alloimmunization when DEL phenotype individuals are inadvertently managed as RhD-negative. This narrative review summarized the DEL alleles causing DEL phenotype and the underlying mechanisms. The clinical consequences and current molecular testing approach were discussed to manage the transfusion needs of patients and donors with DEL phenotype.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adzhubei IA, Schmidt S, Peshkin L et al (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248–249. https://doi.org/10.1038/nmeth0410-248
Borgmann DM, Mayr S, Polin H et al (2016) Single Molecule fluorescence microscopy and machine learning for rhesus D antigen classification. Sci Rep 6:32317. https://doi.org/10.1038/srep32317
Chen DP, Sun CF, Ning HC, Wang WT, Tseng CP (2016) Comprehensive analysis of RHD splicing transcripts reveals the molecular basis for the weak anti-D reactivity of Del -red blood cells. Transfus Med 26:123–129. https://doi.org/10.1111/tme.12270
Chen JC, Lin TM, Chen YL, Wang YH, Jin YT, Yue CT (2004) RHD 1227A is an important genetic marker for RhD(el) individuals. Am J Clin Pathol 122:193–198. https://doi.org/10.1309/3XMF-2NV5-707T-JE7X
Chen Q, Flegel WA (2005) Random survey for RHD alleles among D+ European persons. Transfusion 45:1183–1191. https://doi.org/10.1111/j.1537-2995.2005.00181.x
Chen Q, Li M, Li M, Lu XS, Lu R, Sun J, Liu Z (2012) Molecular basis of weak D and DEL in Han population in Anhui Province, China. Chin Med J (Engl) 125:3251–3255 https://www.ncbi.nlm.nih.gov/pubmed/22964318
Chen Q, Liu Z (2012) Retrospective analysis of transfusion DEL blood to RhD-negative receipents. Transfusion 52:36A https://www.ncbi.nlm.nih.gov/pubmed/29043831
Chen W, Li L, Tsai SL, Lin K (2006) Anti-D immunization by Del red blood cells in Taiwan: two case reports. Transfusion 25(Suppl I):129A
Chiba Y, Matsuhashi A, Onodera Y (2021) Anti-D production suspected case by transfusion of Del red blood cells. Japanese Journal of Transfusion and Cell Therapy 67:297
Chou ST, Flanagan JM, Vege S, Luban NLC, Brown RC, Ware RE, Westhoff CM (2017) Whole-exome sequencing for RH genotyping and alloimmunization risk in children with sickle cell anemia. Blood Adv 1:1414–1422. https://doi.org/10.1182/bloodadvances.2017007898
Christiansen M, Sorensen BS, Grunnet N (2010) RHD positive among C/E+ and D- blood donors in Denmark. Transfusion 50:1460–1464. https://doi.org/10.1111/j.1537-2995.2010.02611.x
Chun S, Lee HJ, Cho D (2020) A new RHD variant allele (RHD Gly339Val) shows weakened D expression compared to RHD Gly339Glu and Gly339Arg mutants. Transfusion 60:E17–E18. https://doi.org/10.1111/trf.15908
Crottet SL, Henny C, Meyer S et al (2014) Implementation of a mandatory donor RHD screening in Switzerland. Transfus Apher Sci 50:169–174. https://doi.org/10.1016/j.transci.2014.02.011
Fichou Y, Chen JM, Le Marechal C et al (2012) Weak D caused by a founder deletion in the RHD gene. Transfusion 52:2348–2355. https://doi.org/10.1111/j.1537-2995.2012.03606.x
Fichou Y, Gehannin P, Corre M, Le Guern A, Le Marechal C, Le Gac G, Ferec C (2015) Extensive functional analyses of RHD splice site variants: insights into the potential role of splicing in the physiology of Rh. Transfusion 55:1432–1443. https://doi.org/10.1111/trf.13083
Flegel WA (2004) (ASH Annual Meeting Abstracts). Blood:Abstract 2706. https://www.ncbi.nlm.nih.gov/pubmed/33240456
Flegel WA (2005) Homing in on D antigen immunogenicity. Transfusion 45:466–468. https://doi.org/10.1111/j.0041-1132.2005.05001.x
Flegel WA (2007) The genetics of the Rhesus blood group system. Blood Transfus 5:50–57. https://doi.org/10.2450/2007.0011-07
Flegel WA (2011) Molecular genetics and clinical applications for RH. Transfus Apher Sci 44:81–91. https://doi.org/10.1016/j.transci.2010.12.013
Flegel WA (2021) Proceed with care: the “uncommon” serologic weak D phenotypes. Blood Transfus 19:272–276. https://doi.org/10.2450/2021.0147-21
Flegel WA, von Zabern I, Wagner FF (2009) Six years’ experience performing RHD genotyping to confirm D- red blood cell units in Germany for preventing anti-D immunizations. Transfusion 49:465–471. https://doi.org/10.1111/j.1537-2995.2008.01975.x
Flegel WA, Wagner FF (2020) Del Prevalence and Populations. Blood Transfus 18:159–162. https://doi.org/10.2450/2020.0296-19
Flegel WA, Wagner FF, Donghaile DP (2020) Anti-D immunization rates may exceed 50% in many clinically relevant settings, despite varying widely among patient cohorts. Transfusion 60:1109–1110. https://doi.org/10.1111/trf.15788
Flegel WA, Wagner FF, Muller TH, Gassner C (1998) Rh phenotype prediction by DNA typing and its application to practice. Transfus Med 8:281–302. https://doi.org/10.1046/j.1365-3148.1998.00173.x
Floch A, Vege S, Berardi P, Hannon J, Ochoa-Garay G, Lomas-Francis C, Westhoff CM (2022) An intron c.149-2632T>A change in RHD is associated with aberrant transcription and very weak D phenotype. Transfusion 62:E14–E16. https://doi.org/10.1111/trf.16774
Flommersfeld S, Mand C, Kuhne CA, Bein G, Ruchholtz S, Sachs UJ (2018) Unmatched type O RhD+ red blood cells in multiple injured patients. Transfus Med Hemother 45:158–161. https://doi.org/10.1159/000485388
Fujita Y, Tanaka K, Tanimura M (1978) The distribution of the Rh(D) blood types in Japan. Jinrui Idengaku Zasshi 23:197–209. https://doi.org/10.1007/BF01872469
Garcia F, Rodriguez MA, Goldman M et al (2015) New RHD variant alleles. Transfusion 55:427–429. https://doi.org/10.1111/trf.12828
Gardener GJ, Legler TJ, Hyett JA, Liew YW, Flower RL, Hyland CA (2012) Anti-D in pregnant women with the RHD(IVS3+1G>A)-associated DEL phenotype. Transfusion 52:2016–2019. https://doi.org/10.1111/j.1537-2995.2011.03538.x
Gassner C, Doescher A, Drnovsek TD et al (2005) Presence of RHD in serologically D-, C/E+ individuals: a European multicenter study. Transfusion 45:527–538. https://doi.org/10.1111/j.0041-1132.2004.04211.x
Gowland P, Gassner C, Hustinx H et al (2014) Molecular RHD screening of RhD negative donors can replace standard serological testing for RhD negative donors. Transfus Apher Sci 50:163–168. https://doi.org/10.1016/j.transci.2014.02.009
Gu J, Wang XD, Shao CP, Wang J, Sun AY, Huang LH, Pan ZL (2014) Molecular basis of DEL phenotype in the Chinese population. BMC Med Genet 15:54. https://doi.org/10.1186/1471-2350-15-54
Ito S, Ohto H, Ogiyama Y et al (2021) A practical and effective strategy in East Asia to prevent anti-D alloimmunization in patients by C/c phenotyping of serologic RhD-negative blood donors. EJHaem 2:750–756. https://doi.org/10.1002/jha2.292
Ji Y, Luo G, Fu Y (2022) Incidence of anti-D alloimmunization in D-negative individuals receiving D-positive red blood cell transfusion: a systematic review and meta-analysis. Vox Sang 117:633–640. https://doi.org/10.1111/vox.13232
Ji Y, Luo Y, Wen J et al (2023) Patients with Asian-type DEL can safely be transfused with RhD-positive blood. Blood 141:2141–2150. https://doi.org/10.1182/blood.2022018152
Just B, Deitenbeck R (2014) Sekundäre anti-D-immunisierung bei RhD-negativem Empfänger, verursacht durch ein Del-Erythrozytenkonzentrat. Transfusionsmedizin - Immunhämatologie, Hämotherapie, Immungenetik, Zelltherapie 4:134–138. https://doi.org/10.1055/s-0034-1368630
Kacker S, Vassallo R, Keller MA, Westhoff CM, Frick KD, Sandler SG, Tobian AA (2015) Financial implications of RHD genotyping of pregnant women with a serologic weak D phenotype. Transfusion 55:2095–2103. https://doi.org/10.1111/trf.13074
Kim JY, Kim SY, Kim CA, Yon GS, Park SS (2005) Molecular characterization of D- Korean persons: development of a diagnostic strategy. Transfusion 45:345–352. https://doi.org/10.1111/j.1537-2995.2005.04311.x
Kim KH, Kim KE, Woo KS, Han JY, Kim JM, Park KU (2009) Primary anti-D immunization by DEL red blood cells. Korean J Lab Med 29:361–365. https://doi.org/10.3343/kjlm.2009.29.4.361
Kormoczi GF, Gassner C, Shao CP, Uchikawa M, Legler TJ (2005) A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization. Transfusion 45:1561–1567. https://doi.org/10.1111/j.1537-2995.2005.00584.x
Krog GR, Clausen FB, Berkowicz A, Jorgensen L, Rieneck K, Nielsen LK, Dziegiel MH (2011) Is current serologic RhD typing of blood donors sufficient for avoiding immunization of recipients? Transfusion 51:2278–2285. https://doi.org/10.1111/j.1537-2995.2011.03156.x
Kulkarni SS, Gogri H, Parchure D et al (2018) RHD-positive alleles among D- C/E+ individuals from India. Transfus Med Hemother 45:173–177. https://doi.org/10.1159/000479239
Le Marechal C, Guerry C, Benech C et al (2007) Identification of 12 novel RHD alleles in western France by denaturing high-performance liquid chromatography analysis. Transfusion 47:858–863. https://doi.org/10.1111/j.1537-2995.2005.00631.x-i1
Li JH, Zhang CY, Sun JH, Liu J (2012) Molecular mechanism of RhDel phenotype in blood donation population of Chinese Harbin area. Zhongguo Shi Yan Xue Ye Xue Za Zhi 20:1478–1481 https://www.ncbi.nlm.nih.gov/pubmed/23257457
Li Q, Hou L, Guo ZH, Ye LY, Yue DQ, Zhu ZY (2009) Molecular basis of the RHD gene in blood donors with DEL phenotypes in Shanghai. Vox Sang 97:139–146. https://doi.org/10.1111/j.1423-0410.2009.01181.x
Li Q, Ye LY, Guo ZH, Qian M, Zhu ZY (2006) Study on the molecular background of Del phenotype in Chinese population. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 23:486–491 https://www.ncbi.nlm.nih.gov/pubmed/17029192
Liu C, Xue Y, Ouchari M, Yin Q (2021) Transfusion management of a Chinese pregnant woman with RHD*DEL1 allele. Transfus Clin Biol 28:293–295. https://doi.org/10.1016/j.tracli.2021.05.001
Lopez GH, McGowan EC, Condon JA et al (2017) Genotyping by sequencing defines independent novel RHD variants for an antenatal patient and a blood donor. Transfusion 57:2281–2283. https://doi.org/10.1111/trf.14250
Lopez GH, Turner RM, McGowan EC et al (2018) A DEL phenotype attributed to RHD Exon 9 sequence deletion: slipped-strand mispairing and blood group polymorphisms. Transfusion 58:685–691. https://doi.org/10.1111/trf.14439
Luettringhaus TA, Cho D, Ryang DW, Flegel WA (2006) An easy RHD genotyping strategy for D- East Asian persons applied to Korean blood donors. Transfusion 46:2128–2137. https://doi.org/10.1111/j.1537-2995.2006.01042.x
Mak KH, Yan KF, Cheng SS, Yuen MY (1993) Rh phenotypes of Chinese blood donors in Hong Kong, with special reference to weak D antigens. Transfusion 33:348–351. https://doi.org/10.1046/j.1537-2995.1993.33493242645.x
Moussa H, Tsochandaridis M, Chakroun T et al (2012) Molecular background of D-negative phenotype in the Tunisian population. Transfus Med 22:192–198. https://doi.org/10.1111/j.1365-3148.2012.01142.x
Ogasawara K, Sasaki K, Isa K, Tsuneyama H, Uchikawa M, Satake M, Tadokoro K (2016) Weak D alleles in Japanese: a c.960G>A silent mutation in exon 7 of the RHD gene that affects D expression. Vox Sang 110:179–184. https://doi.org/10.1111/vox.12322
Ogasawara K, Suzuki Y, Sasaki K et al (2015) Molecular basis for D- Japanese: identification of novel DEL and D- alleles. Vox Sang 109:359–365. https://doi.org/10.1111/vox.12290
Okuda H, Suganuma H, Kamesaki T et al (2000) The analysis of nucleotide substitutions, gaps, and recombination events between RHD and RHCE genes through complete sequencing. Biochem Biophys Res Commun 274:670–683. https://doi.org/10.1006/bbrc.2000.3206
Orzinska A, Guz K, Polin H et al (2013) RHD variants in Polish blood donors routinely typed as D. Transfusion 53:2945–2953. https://doi.org/10.1111/trf.12230
Pham BN, Roussel M, Gien D, Ripaux M, Carine C, Le Pennec PY, Andre-Botte C (2013) Molecular analysis of patients with weak D and serologic analysis of those with anti-D (excluding type 1 and type 2). Immunohematology 29:55–62 https://www.ncbi.nlm.nih.gov/pubmed/24094237
Pisacka M, Kralova J, Hanzikova V et al (2019) Strong pregnancy induced anti-D immunization in del phenotypr with RHD*01EL.04 allele. Vox Sang 114:5A-S29-04
Polin H, Danzer M, Gaszner W et al (2009) Identification of RHD alleles with the potential of anti-D immunization among seemingly D- blood donors in Upper Austria. Transfusion 49:676–681. https://doi.org/10.1111/j.1537-2995.2008.02046.x
Polin H, Danzer M, Hofer K, Gassner W, Gabriel C (2007) Effective molecular RHD typing strategy for blood donations. Transfusion 47:1350–1355. https://doi.org/10.1111/j.1537-2995.2007.01278.x
Richard M, Perreault J, Constanzo-Yanez J, Khalife S, St-Louis M (2007) A new DEL variant caused by exon 8 deletion. Transfusion 47:852–857. https://doi.org/10.1111/j.1537-2995.2007.01199.x
Sakuma K, Kubo N, Nishimura K et al (2010) Anti-D antibody production due to transfusion of del type RBCs to a D-negative recipient: a case report. RHD*DEL1 units 56:381–385. https://doi.org/10.3925/jjtc.56.381
Sandler SG, Flegel WA, Westhoff CM et al (2015) It’s time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group. Transfusion 55:680–689. https://doi.org/10.1111/trf.12941
Selleng K, Jenichen G, Denker K, Selleng S, Mullejans B, Greinacher A (2017) Emergency transfusion of patients with unknown blood type with blood group O Rhesus D positive red blood cell concentrates: a prospective, single-centre, observational study. Lancet Haematol 4:e218–e224. https://doi.org/10.1016/S2352-3026(17)30051-0
Shao CP (2010) Transfusion of RhD-positive blood in “Asia type” DEL recipients. N Engl J Med 362:472–473. https://doi.org/10.1056/NEJMc0909552
Shao CP, Maas JH, Su YQ, Kohler M, Legler TJ (2002) Molecular background of Rh D-positive, D-negative, D(el) and weak D phenotypes in Chinese. Vox Sang 83:156–161. https://doi.org/10.1046/j.1423-0410.2002.00192.x
Shao CP, Wang BY, Ye SH et al (2012) DEL RBC transfusion should be avoided in particular blood recipient in East Asia due to allosensitization and ineffectiveness. J Zhejiang Univ Sci B 13:913–918. https://doi.org/10.1631/jzus.B1100348
Shao CP, Xu H, Xu Q et al (2010) Antenatal Rh prophylaxis is unnecessary for “Asia type” DEL women. Transfus Clin Biol 17:260–264. https://doi.org/10.1016/j.tracli.2010.07.003
Silvy M, Simon S, Gouvitsos J, Di Cristofaro J, Ferrera V, Chiaroni J, Bailly P (2011) Weak D and DEL alleles detected by routine SNaPshot genotyping: identification of four novel RHD alleles. Transfusion 51:401–411. https://doi.org/10.1111/j.1537-2995.2010.02830.x
Simsek S, Bleeker PM, von dem Borne AE (1994) Prenatal determination of fetal RhD type. N Engl J Med 330:795–796. https://doi.org/10.1056/NEJM199403173301122
Singleton BK, Green CA, Avent ND et al (2000) The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in africans with the Rh D-negative blood group phenotype. Blood 95:12–18 https://www.ncbi.nlm.nih.gov/pubmed/10607679
Srijinda S, Suwanasophon C, Visawapoka U, Pongsavee M (2012) RhC phenotyping, adsorption/elution test, and SSP-PCR: the combined test for D-elute phenotype screening in Thai RhD-negative blood donors. ISRN Hematol 2012:358316. https://doi.org/10.5402/2012/358316
Srivastava K, Stiles DA, Wagner FF, Flegel WA (2018) Two large deletions extending beyond either end of the RHD gene and their red cell phenotypes. J Hum Genet 63:27–35. https://doi.org/10.1038/s10038-017-0345-3
Stegmann TC, Veldhuisen B, Bijman R et al (2016) Frequency and characterization of known and novel RHD variant alleles in 37 782 Dutch D-negative pregnant women. Br J Haematol 173:469–479. https://doi.org/10.1111/bjh.13960
Stettler J, Lejon Crottet S, Still F, Graber J, Niederhauser C, Waldvogel S, Henny C (2020) Reduced RhD antigen expression caused by two novel RHD variant alleles. Transfusion 60:E7–E8. https://doi.org/10.1111/trf.15714
St-Louis M, Lebrun A, Goldman M, Lavoie M (2013) Alloimmunization of patients by blood units harboring distinct DEL variants. Immunohematology 29:136–140 https://www.ncbi.nlm.nih.gov/pubmed/24689683
St-Louis R (2012) Characterization of novel RHD alleles: relationship between phenotype, genotype, and trimeric architecture. Vox Sanguinis 103(Suppl. 1). https://doi.org/10.1111/j.1537-2995.2011.03544.x
Touinssi M, Chapel-Fernandes S, Granier T, Bokilo A, Bailly P, Chiaroni J (2009) Molecular analysis of inactive and active RHD alleles in native Congolese cohorts. Transfusion 49:1353–1360. https://doi.org/10.1111/j.1537-2995.2009.02161.x
Trucco Boggione C, Lujan Brajovich ME, Tarrago M et al (2014) Molecular structures identified in serologically D- samples of an admixed population. Transfusion 54:2456–2462. https://doi.org/10.1111/trf.12691
Trucco Boggione C, Nogues N, Gonzalez-Santesteban C et al (2019) Characterization of RHD locus polymorphism in D negative and D variant donors from Northwestern Argentina. Transfusion 59:3236–3242. https://doi.org/10.1111/trf.15504
Tsutsumi Y, S I (2006) Anti-D production in a RhD negative patient following tranfusion of DEL red blood cells. Jpn J Transfus Med 52:267
Turley E, McGowan EC, Hyland CA et al (2018) Severe hemolytic disease of the fetus and newborn due to allo-anti-D in a patient with a partial DEL phenotype arising from the variant allele described as RHD*148+1T (RHD*01EL.31). Transfusion 58:2260–2264. https://doi.org/10.1111/trf.14944
Wagner FF (2013) RHD PCR of D-negative blood donors. Transfus Med Hemother 40:172–181. https://doi.org/10.1159/000351604
Wagner FF, Eicher NI, Jorgensen JR, Lonicer CB, Flegel WA (2002) DNB: a partial D with anti-D frequent in Central Europe. Blood 100:2253–2256. https://doi.org/10.1182/blood-2002-03-0742
Wagner FF, Flegel WA (2000) RHD gene deletion occurred in the Rhesus box. Blood 95:3662–3668 https://www.ncbi.nlm.nih.gov/pubmed/10845894
Wagner FF, Flegel WA (2004) Review: the molecular basis of the Rh blood group phenotypes. Immunohematology 20:23–36 https://www.ncbi.nlm.nih.gov/pubmed/15373666
Wagner FF, Flegel WA (2014) The rhesus site. Transfus Med Hemother 41:357–363. https://doi.org/10.1159/000366176
Wagner FF, Frohmajer A, Flegel WA (2001) RHD positive haplotypes in D negative Europeans. BMC Genet 2:10. https://doi.org/10.1186/1471-2156-2-10
Wagner FF, Moulds JM, Flegel WA (2005a) Genetic mechanisms of Rhesus box variation. Transfusion 45:338–344. https://doi.org/10.1111/j.1537-2995.2005.04339.x
Wagner T, Kormoczi GF, Buchta C, Vadon M, Lanzer G, Mayr WR, Legler TJ (2005b) Anti-D immunization by DEL red blood cells. Transfusion 45:520–526. https://doi.org/10.1111/j.0041-1132.2005.04256.x
Wang M, Wang BL, Xu W et al (2015) Anti-D alloimmunisation in pregnant women with DEL phenotype in China. Transfus Med 25:163–169. https://doi.org/10.1111/tme.12211
Wang QP, Dong GT, Wang XD et al (2014) An investigation of secondary anti-D immunisation among phenotypically RhD-negative individuals in the Chinese population. Blood Transfus 12:238–243. https://doi.org/10.2450/2013.0184-12
Wu X, Wu D, Wang M, Shao C, Xu H (2014) Analysis of frequency of a RHD1227A allele in Chinese Hans. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 31:793–796. https://doi.org/10.3760/cma.j.issn.1003-9406.2014.06.026
Xu W, Zhu M, Wang BL, Su H, Wang M (2015) Prospective evaluation of a transfusion policy of RhD-positive red blood cells into DEL patients in China. Transfus Med Hemother 42:15–21. https://doi.org/10.1159/000370217
Yang HS, Lee MY, Park TS et al (2015) Primary anti-D alloimmunization induced by “Asian type” RHD (c.1227G>A) DEL red cell transfusion. Ann Lab Med 35:554–556. https://doi.org/10.3343/alm.2015.35.5.554
Yasuda H, Ohto H, Sakuma S, Ishikawa Y (2005) Secondary anti-D immunization by Del red blood cells. Transfusion 45:1581–1584. https://doi.org/10.1111/j.1537-2995.2005.00579.x
Ye L, He Y, Gao H, Guo Z, Zhu Z (2013) Weak D phenotypes caused by intronic mutations in the RHD gene: four novel weak D alleles identified in the Chinese population. Transfusion 53:1829–1833. https://doi.org/10.1111/trf.12002
Yin Q, Flegel WA (2021) DEL in China: the D antigen among serologic RhD-negative individuals. J Transl Med 19:439. https://doi.org/10.1186/s12967-021-03116-6
Yoon J, Koh YE, Kim HN et al (2016) A case of primary anti-D alloimmunization by RHD(c.1227G>A) DE: red blood cell transfusion. Korean. J Blood Transfusion 27(2):169–173
Funding
This study was financially supported by Fundamental Research Funds for the Henan University of Science and Technology (QNY)
Ethics declarations
Ethics approval and consent participate
Not applicable
Animal ethics
Not applicable
Conflict of interest
The author declares no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yin, Q. DEL variants: review of molecular mechanisms, clinical consequences and molecular testing strategy. Funct Integr Genomics 23, 318 (2023). https://doi.org/10.1007/s10142-023-01249-z
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10142-023-01249-z